CN105873922B - 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 - Google Patents

9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 Download PDF

Info

Publication number
CN105873922B
CN105873922B CN201480071487.0A CN201480071487A CN105873922B CN 105873922 B CN105873922 B CN 105873922B CN 201480071487 A CN201480071487 A CN 201480071487A CN 105873922 B CN105873922 B CN 105873922B
Authority
CN
China
Prior art keywords
alkyl
compound
diyl
tetrafluoro
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480071487.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN105873922A (zh
Inventor
王勇
赵立文
王德忠
周海平
张先
陈宏雁
张迪
张仓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Sanhome Pharmaceutical Co Ltd
Original Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Sanhome Pharmaceutical Co Ltd filed Critical Nanjing Sanhome Pharmaceutical Co Ltd
Publication of CN105873922A publication Critical patent/CN105873922A/zh
Application granted granted Critical
Publication of CN105873922B publication Critical patent/CN105873922B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201480071487.0A 2013-12-31 2014-12-26 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 Active CN105873922B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2013107543184 2013-12-31
CN201310754318 2013-12-31
PCT/CN2014/095043 WO2015101215A1 (zh) 2013-12-31 2014-12-26 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用

Publications (2)

Publication Number Publication Date
CN105873922A CN105873922A (zh) 2016-08-17
CN105873922B true CN105873922B (zh) 2018-08-14

Family

ID=53493209

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480071487.0A Active CN105873922B (zh) 2013-12-31 2014-12-26 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用
CN201410835606.7A Active CN104744444B (zh) 2013-12-31 2014-12-29 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410835606.7A Active CN104744444B (zh) 2013-12-31 2014-12-29 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用

Country Status (9)

Country Link
US (1) US9512108B2 (enExample)
EP (1) EP3091010A4 (enExample)
JP (1) JP2017536329A (enExample)
KR (1) KR101857689B1 (enExample)
CN (2) CN105873922B (enExample)
AU (1) AU2014375584B2 (enExample)
CA (1) CA2935089C (enExample)
TW (1) TWI532735B (enExample)
WO (1) WO2015101215A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107266424A (zh) * 2016-04-07 2017-10-20 南京圣和药业股份有限公司 二氢菲类化合物及其制备方法
CN108623569A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物的制备方法
CN108623570A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物、其制备方法及用途
CN108619102A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 一种包含丙型肝炎病毒抑制剂的药物组合物及其制备方法
CN108623568B (zh) * 2017-03-21 2022-04-19 南京汇诚制药有限公司 9,10二氢菲类丙型肝炎病毒抑制剂的盐型及其制备
CN109419806B (zh) * 2017-08-23 2023-06-20 南京圣和药业股份有限公司 抗病毒组合物及其应用
CN114890916A (zh) * 2022-04-25 2022-08-12 常州吉恩药业有限公司 一种n-甲氧羰基-l-叔亮氨酸的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012068234A2 (en) * 2010-11-17 2012-05-24 Gilead Sciences, Inc. Antiviral compounds
CN102596936A (zh) * 2009-05-13 2012-07-18 吉里德科学公司 抗病毒化合物
WO2013028953A1 (en) * 2011-08-24 2013-02-28 Glaxosmithkline Llc Combination treatments for hepatitis c

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524230A1 (de) * 1995-07-04 1997-01-09 Hoechst Ag Fluorierte Phenanthren-Derivate und ihre Verwendung in flüssigkristallinen Mischungen
US6455744B1 (en) * 2001-01-23 2002-09-24 Air Products And Chemicals, Inc. Synthesis of vicinal difluoro aromatics and intermediates thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102596936A (zh) * 2009-05-13 2012-07-18 吉里德科学公司 抗病毒化合物
WO2012068234A2 (en) * 2010-11-17 2012-05-24 Gilead Sciences, Inc. Antiviral compounds
WO2013028953A1 (en) * 2011-08-24 2013-02-28 Glaxosmithkline Llc Combination treatments for hepatitis c

Also Published As

Publication number Publication date
CN105873922A (zh) 2016-08-17
KR20160058187A (ko) 2016-05-24
JP2017536329A (ja) 2017-12-07
CA2935089A1 (en) 2015-07-09
TW201524973A (zh) 2015-07-01
CN104744444B (zh) 2019-02-26
KR101857689B1 (ko) 2018-05-14
CA2935089C (en) 2018-11-27
AU2014375584B2 (en) 2017-11-09
US9512108B2 (en) 2016-12-06
TWI532735B (zh) 2016-05-11
EP3091010A1 (en) 2016-11-09
CN104744444A (zh) 2015-07-01
EP3091010A4 (en) 2017-10-04
US20160297804A1 (en) 2016-10-13
WO2015101215A1 (zh) 2015-07-09
AU2014375584A1 (en) 2016-07-07
HK1222845A1 (zh) 2017-07-14

Similar Documents

Publication Publication Date Title
CN105873922B (zh) 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用
TWI438200B (zh) C型肝炎病毒抑制劑
ES2383388T3 (es) Inhibidores del virus de la hepatitis C
CN102459250B (zh) 丙型肝炎病毒抑制剂
CN102378762B (zh) 丙型肝炎病毒抑制剂
CN102863428B (zh) 作为丙型肝炎病毒抑制剂的螺环化合物
CN102015692A (zh) 丙型肝炎病毒抑制剂
CN104230946B (zh) 抑制丙肝病毒的化合物、药物组合物及其应用
CN104725365B (zh) 丙型肝炎病毒抑制剂及其应用
AU2010274001A1 (en) Benzimidazole analogues for the treatment or prevention of Flavivirus infections
SG171890A1 (en) Inhibitors of hcv ns5a
KR20120130173A (ko) 플라비바이러스 감염을 치료 또는 예방하기 위한 유사체들
JP2014534206A (ja) C型肝炎ウイルス阻害剤
CN103420991A (zh) 作为丙型肝炎抑制剂的吡咯烷衍生物及其在药物中的应用
TW201439060A (zh) 作爲丙型肝炎抑制劑的橋環化合物及其藥物組合物和用途
CN106008552B (zh) 苯并[e]吡唑并[1,5-c][1,3]噁嗪类化合物及其应用
AU2014396578A1 (en) Compounds for inhibiting hepatitis C virus, pharmaceutical compositions and uses thereof
CN107074876B (zh) 一类抑制丙肝病毒的大环状杂环化合物及其制备和用途
HK1222845B (zh) 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用
CN108348504B (zh) 具有抑制hcv活性的化合物及其制备方法和应用
CN105985355B (zh) 稠合三环类肝炎病毒抑制剂及其应用
WO2017088730A1 (zh) 用于抗丙型肝炎病毒感染的含硅化合物
JP2020512331A (ja) 抗c型肝炎ウイルス感染のためのケイ素含有化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1222845

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant